Abstract

The ready availability of human blood makes it the first choice for immuno-monitoring. However, this has been largely confined to static metrics, particularly resting T cell phenotypes. Conversely, dynamic assessments have mostly relied on cell stimulation in vitro which is subject to multiple variables. Here, immunodynamic insights from the peripheral blood are shown to be obtainable by applying a revised approach to cell-cycle analysis. Specifically, refined flow cytometric protocols were employed, assuring the reliable quantification of T cells in the S-G2/M phases of the cell-cycle (collectively termed “T Double S” for T cells in S-phase in Sanguine: in short “TDS” cells). Without protocol refinement, TDS could be either missed, as most of them layed out of the conventional lymphocyte gates, or confused with cell doublets artefactually displaying high DNA-content. To illustrate the nature of TDS cells, and their relationship to different immunodynamic scenarios, we examined them in healthy donors (HD); infectious mononucleosis (IM) patients versus asymptomatic EBV+ carriers; and recently-diagnosed T1D patients. TDS were reproducibly more abundant among CD8+ T cells and a defined subset of T-regulatory CD4+ T cells, and were substantially increased in IM and a subset of T1D patients. Of note, islet antigen-reactive TDS cell frequencies were associated with an aggressive T cell effector phenotype, suggesting that peripheral blood can reflect immune events within tissues in T1D, and possibly in other organ-specific autoimmune diseases.Our results suggest that tracking TDS cells may provide a widely applicable means of gaining insight into ongoing immune response dynamics in a variety of settings, including tissue immunopathologies where the peripheral blood has often not been considered insightful.

Highlights

  • Clonal expansions of adaptive lymphocytes underpin host-beneficial responses to infection, vaccination, and cancer, yet can be responsible for graft rejection and for self-antigen targeting in chronic autoimmune diseases, such as Type 1 Diabetes (T1D)

  • To illustrate the nature of TDS cells, and their relationship to different immunodynamic scenarios, we examined them in healthy donors (HD); infectious mononucleosis (IM) patients versus asymptomatic EBV+ carriers; and recently-diagnosed T1D patients

  • Our focus was on CD8+ T cells, TDS cells could be found in other compartments, Fraction II Treg cells

Read more

Summary

Introduction

Clonal expansions of adaptive lymphocytes underpin host-beneficial responses to infection, vaccination, and cancer, yet can be responsible for graft rejection and for self-antigen targeting in chronic autoimmune diseases, such as Type 1 Diabetes (T1D) In all these scenarios, it would be useful to assess the status and dynamics of ongoing adaptive immune responses, for which peripheral blood is the most utilitarian source [1]. Given that clonal behavior underpins adaptive immunity, single cell resolution is essential for monitoring immune responses This is a power of flow cytometry, peripheral blood analyses have been limited almost exclusively to “snap-shot” assessments of cell phenotypes, with the cells’ dynamic status only revealed by re-stimulation in vitro, which is widely acknowledged to be influenced by many variables. We revisited this issue, choosing to re-evaluate peripheral blood cell-cycle status

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call